跳到正文

Platinum Investment Management Ltd 13F 持仓 · 2026年Q2

Platinum Investment Management 在 2026年Q2(报告期截至 2026-06-30)的 SEC 13F 申报中报告了 85 只证券,申报市值合计 4.07 亿美元。前几大持仓:ZTO(10.97%)、MU(5.05%)、LRCX(4.95%)。本季前 25 大持仓中:增持 2 只、减持 4 只。

排名代码公司市值占组合股数变动
1ZTOZTO EXPRESS CAYMAN INC$44.6M10.97%2.0M持平
2MUMICRON TECHNOLOGY INC$20.5M5.05%17,782减持
3LRCXLAM RESEARCH CORP$20.1M4.95%46,439持平
4TCOMTRIP COM GROUP LTD$14.0M3.45%351,921减持
5DDLDINGDONG CAYMAN LTD$12.5M3.08%6.5M持平
6NOAHNOAH HLDGS LTD$9.9M2.44%993,612持平
7AVGOBROADCOM INC$9.9M2.43%26,186持平
8BIRKBIRKENSTOCK HOLDING PLC$9.0M2.22%210,000减持
9AZNASTRAZENECA PLC$9.0M2.21%48,088持平
10GOOGALPHABET INC$8.7M2.14%24,592持平
11MRKMERCK & CO INC$8.1M2.00%63,316持平
12APGEAPOGEE THERAPEUTICS INC$7.7M1.90%58,314持平
13ABBVABBVIE INC$7.6M1.86%30,102持平
14JNJJOHNSON & JOHNSON$7.1M1.74%27,830持平
15YUMYUM BRANDS INC$6.4M1.57%39,847持平
16COGTCOGENT BIOSCIENCES INC$6.0M1.47%154,220增持
17PDDPDD HOLDINGS INC$6.0M1.47%78,445持平
18UBSUBS GROUP AG$5.8M1.43%117,507持平
19NVDANVIDIA CORPORATION$5.6M1.39%28,191持平
20IMVTIMMUNOVANT INC$5.6M1.37%144,671减持
21ARWRARROWHEAD PHARMACEUTICALS IN$5.3M1.30%64,752持平
22IDYAIDEAYA BIOSCIENCES INC$5.2M1.27%138,708增持
23IQVIQVIA HLDGS INC$5.2M1.27%26,708持平
24HTHTH WORLD GROUP LTD$4.9M1.21%117,996持平
25VERAVERA THERAPEUTICS INC$4.9M1.20%113,687持平

来源:SEC 13F 申报文件 · 截至 2026-06-30

本期 13F-HR 中的全部持仓,以及相对上季度的变化。

13F 持仓,最新季度

来源SEC EDGAR13F-HR